240 related articles for article (PubMed ID: 29484562)
1. Concurrent Versus Sequential Chemoradiation Therapy in Completely Resected Pathologic N2 Non-Small Cell Lung Cancer: Propensity-Matched Analysis of the National Cancer Data Base.
Moreno AC; Haque W; Verma V; Fang P; Lin SH
Ann Surg Oncol; 2018 May; 25(5):1245-1253. PubMed ID: 29484562
[TBL] [Abstract][Full Text] [Related]
2. Sequential Versus Concurrent Chemoradiation Therapy by Surgical Margin Status in Resected Non-Small Cell Lung Cancer.
Verma V; Moreno AC; Haque W; Fang P; Lin SH
J Natl Compr Canc Netw; 2018 May; 16(5):508-516. PubMed ID: 29752325
[No Abstract] [Full Text] [Related]
3. Sequencing of Postoperative Radiotherapy and Chemotherapy for Locally Advanced or Incompletely Resected Non-Small-Cell Lung Cancer.
Francis S; Orton A; Stoddard G; Tao R; Hitchcock YJ; Akerley W; Kokeny KE
J Clin Oncol; 2018 Feb; 36(4):333-341. PubMed ID: 29236592
[TBL] [Abstract][Full Text] [Related]
4. Surgery Versus Chemotherapy and Radiotherapy For Early and Locally Advanced Small Cell Lung Cancer: A Propensity-Matched Analysis of Survival.
Wakeam E; Acuna SA; Leighl NB; Giuliani ME; Finlayson SRG; Varghese TK; Darling GE
Lung Cancer; 2017 Jul; 109():78-88. PubMed ID: 28577955
[TBL] [Abstract][Full Text] [Related]
5. [Concurrent chemoradiotherapy followed by consolidation chemotherapy and sequential chemoradiotherapy for stage III non-small cell lung cancer: comparison in 93 patients].
Sun WZ; Song LP; Zhang YB; Ai T; Lu JL; Ren J; Gao Y
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):362-7. PubMed ID: 22445984
[TBL] [Abstract][Full Text] [Related]
6. Induction chemoimmunotherapy with surgery versus concurrent chemoradiation followed by immunotherapy for stage III-N2 non-small cell lung cancer.
Kumar A; Srinivasan D; Potter AL; Mathey-Andrews C; Lanuti M; Martin LW; Jeffrey Yang CF
J Thorac Cardiovasc Surg; 2024 Jun; 167(6):1895-1905.e2. PubMed ID: 37722622
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant Management of Pathologic Node-Positive Disease After Definitive Surgery for Clinical T1-2 N0 Rectal Cancer.
Polamraju P; Haque W; Verma V; Wiederhold L; Hatch S; Butler EB; Teh BS
Clin Colorectal Cancer; 2018 Sep; 17(3):e519-e530. PubMed ID: 29753642
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database.
Ecker BL; McMillan MT; Datta J; Lee MK; Karakousis GC; Vollmer CM; Drebin JA; Fraker DL; Roses RE
Cancer; 2017 May; 123(6):967-976. PubMed ID: 28263387
[TBL] [Abstract][Full Text] [Related]
9. Improved Survival With Increased Time-To-Radiation and Sequential Chemotherapy After Surgery for pN2 Non-Small-cell Lung Cancer.
Sura K; Grills IS; Vu CC; Stevens CW; Ye H; Guerrero TM
Clin Lung Cancer; 2018 Mar; 19(2):e185-e194. PubMed ID: 29158124
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of neoadjuvant concurrent chemoradiotherapy followed by surgery for non-small-cell lung cancer with N2 disease.
Kim HK; Cho JH; Choi YS; Zo JI; Shim YM; Park K; Ahn MJ; Ahn YC; Kim K; Kim J
Lung Cancer; 2016 Jun; 96():56-62. PubMed ID: 27133751
[TBL] [Abstract][Full Text] [Related]
11. Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base.
Sher DJ; Koshy M; Liptay MJ; Fidler MJ
Cancer; 2014 Jul; 120(13):2060-8. PubMed ID: 24692108
[TBL] [Abstract][Full Text] [Related]
12. Adding Radiotherapy to Adjuvant Chemotherapy Does Not Improve Survival of Patients With N2 Lung Cancer.
Drake JA; Portnoy DC; Tauer K; Weksler B
Ann Thorac Surg; 2018 Oct; 106(4):959-965. PubMed ID: 29856974
[TBL] [Abstract][Full Text] [Related]
13. Concurrent chemotherapy is associated with improved survival in elderly patients with bladder cancer undergoing radiotherapy.
Korpics MC; Block AM; Martin B; Hentz C; Gaynor ER; Henry E; Harkenrider MM; Solanki AA
Cancer; 2017 Sep; 123(18):3524-3531. PubMed ID: 28581675
[TBL] [Abstract][Full Text] [Related]
14. Role of postoperative radiotherapy after curative resection and adjuvant chemotherapy for patients with pathological stage N2 non-small-cell lung cancer: a propensity score matching analysis.
Kim BH; Kim HJ; Wu HG; Kang CH; Kim YT; Lee SH; Kim DW
Clin Lung Cancer; 2014 Sep; 15(5):356-64. PubMed ID: 24996882
[TBL] [Abstract][Full Text] [Related]
15. Combined treatment modalities in Pancoast tumor: results of a monocentric retrospective study.
Jeannin G; Merle P; Janicot H; Thibonnier L; Kwiatkowski F; Naame A; Chadeyras JB; Galvaing G; Belliere A; Filaire M; Verrelle P
Chin Clin Oncol; 2015 Dec; 4(4):39. PubMed ID: 26730751
[TBL] [Abstract][Full Text] [Related]
16. Management of pathologic node-positive disease following initial surgery for clinical T1-2 N0 esophageal cancer: patterns of care and outcomes from the national cancer data base.
Haque W; Verma V; Bernicker E; Butler EB; Teh BS
Acta Oncol; 2018 Jun; 57(6):782-789. PubMed ID: 29188742
[TBL] [Abstract][Full Text] [Related]
17. Concurrent Versus Sequential Chemoradiation for Low-grade Gliomas Meeting RTOG 9802 Criteria.
Ryckman JM; Appiah AK; Lyden E; Verma V; Zhang C
Am J Clin Oncol; 2019 Apr; 42(4):391-398. PubMed ID: 30768441
[TBL] [Abstract][Full Text] [Related]
18. Patterns of Care and Outcomes of Hypofractionated Chemoradiation Versus Conventionally Fractionated Chemoradiation for Glioblastoma in the Elderly Population.
Haque W; Verma V; Butler EB; Teh BS
Am J Clin Oncol; 2018 Feb; 41(2):167-172. PubMed ID: 29369825
[TBL] [Abstract][Full Text] [Related]
19. Role of Chemoradiotherapy in Elderly Patients With Limited-Stage Small-Cell Lung Cancer.
Corso CD; Rutter CE; Park HS; Lester-Coll NH; Kim AW; Wilson LD; Husain ZA; Lilenbaum RC; Yu JB; Decker RH
J Clin Oncol; 2015 Dec; 33(36):4240-6. PubMed ID: 26481366
[TBL] [Abstract][Full Text] [Related]
20. Postoperative radiotherapy is associated with better survival in non-small cell lung cancer with involved N2 lymph nodes: results of an analysis of the National Cancer Data Base.
Mikell JL; Gillespie TW; Hall WA; Nickleach DC; Liu Y; Lipscomb J; Ramalingam SS; Rajpara RS; Force SD; Fernandez FG; Owonikoko TK; Pillai RN; Khuri FR; Curran WJ; Higgins KA
J Thorac Oncol; 2015 Mar; 10(3):462-71. PubMed ID: 25384064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
